StockTipsArenaBeta

BUY Epigral Limited — Rajesh Satpute

BUYEpigral Limited
Epigral share price target & all analyst calls

byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))24 Jul 2026via CNBC Awaaz.

Entry₹1,177Inferred
Target₹1,235
Total upside +4.93% (call closed)
Stop loss₹1,150-2.29% risk
Exit₹1,15027 Jul 2026, 1:55 pm
Stop-loss hit-2.29%
Follow Rajesh Satpute for new calls(31% target hit, 200 closed calls)Get alertsWatch EPIGRAL for new buy/sell callsGet alertsSee 151 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 27 Jul 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·23 Jul · 3d ago

Neutral / worth noting (1)

Epigral Limited's bank facilities have been reaffirmed with a Long Term Rating of CRISIL AA/Stable and a Short Term Rating of CRISIL A1+. The total bank loan facilities rated amount to Rs. 1050 Crore.

BSE · Company Update·14 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Epigral

All analyst calls on Epigral

More from Rajesh Satpute

Every call and its outcome